Cardiac mast cells cause atrial fibrillation through PDGF-A - Mediated fibrosis in pressure-overloaded mouse hearts

Journal of Clinical Investigation

Volumn 120, Issue 1, 2010, Pages 242-253

  Liao, Chien Hui ^a,b   Akazawa, Hiroshi ^a   Tamagawa, Masaji ^a   Ito, Kaoru ^a   Yasuda, Noritaka ^a   Kudo, Yoko ^a   Yamamoto, Rie ^a   Ozasa, Yukako ^a   Fujimoto, Masanori ^a   Wang, Ping ^a   Nakauchi, Hiromitsu ^b   Nakaya, Haruaki ^a   Komuro, Issei ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CROMOGLYCATE DISODIUM; CYTOKINE ANTIBODY; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR A; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BONE MARROW CELL; CELL INFILTRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; FIBROBLAST; HEART ARRHYTHMIA; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART STRESS; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; MALE; MAST CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; FIBROSIS; HEART MUSCLE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ATRIAL FIBRILLATION; BLOOD PRESSURE; BONE MARROW CELLS; CROMOLYN SODIUM; FIBROSIS; MAST CELLS; MICE; MICE, INBRED C57BL; MYOCARDIUM; MYOCYTES, CARDIAC; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA;

EID: 74949085470     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI39942     Document Type: Article

References (46)

1. Fuster V, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation. 2006;114(7):e257-354.
2. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002;415(6868):219-226.
3. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51(8):802-809.
4. Corradi D, Callegari S, Maestri R, Benussi S, Alfieri O. Structural remodeling in atrial fibrillation. Nat Clin Pract Cardiovasc Med. 2008;5(12):782-796.
5. Frustaci A, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96(4):1180-1184.
6. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50(21):2021-2028.
7. Nakamura Y, et al. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thromb Res. 2003;111(3):137-142.
8. Verheule S, et al. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation. 2003;107(20):2615-2622.
9. Chung MK, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104(24):2886-2891.
10. Aviles RJ, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108(24):3006-3010.
11. Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nat Immunol. 2008;9(11):1215-1223.
12. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev. 2007;217:304-328.
13. Sperr WR, et al. The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. Blood. 1994;84(11):3876-3884.
14. Bot I, et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation. 2007;115(19):2516-2525.
15. Sun J, et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med. 2007;13(6):719-724.
16. Sun J, et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest. 2007;117(11):3359- 3368.
17. Tsuruda T, et al. Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm. Circ Res. 2008;102(11):1368-1377.
18. Hara M, et al. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med. 2002;195(3):375-381.
19. Higuchi H, et al. Mast cells play a critical role in the pathogenesis of viral myocarditis. Circulation. 2008;118(4):363-372.
20. Mackins CJ, et al. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest. 2006;116(4):1063-1070.
21. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest. 1997;99(6):1313- 1321.
22. Kondo S, et al. Role of mast cell tryptase in renal interstitial fibrosis. J Am Soc Nephrol. 2001;12(8):1668-1676.
23. Mori R, Shaw TJ, Martin P. Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med. 2008;205(1):43-51.
24. Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev. 2007;217:65-78.
25. Sano M, et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature. 2007;446(7134):444-448.
26. Tharp MD, Seelig LL Jr, Tigelaar RE, Bergstresser PR. Conjugated avidin binds to mast cell granules. J Histochem Cytochem. 1985;33(1):27-32.
27. Zymek P, et al. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol. 2006;48(11):2315-2323.
28. Olgin JE, Verheule S. Transgenic and knockout mouse models of atrial arrhythmias. Cardiovasc Res. 2002;54(2):280-286.
29. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood. 1978;52(2):447-452.
30. Huizinga JD, et al. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature. 1995;373(6512):347-349.
31. Li M, et al. c-kit is required for cardiomyocyte terminal differentiation. Circ Res. 2008;102(6):677-685.
32. Lewis JP, O'Grady LF, Bernstein SE, Russell EE, Trobaugh FE, Jr. Growth and differentiation of transplanted W/Wv marrow. Blood. 1967;30(5):601-616.
33. Patella V, et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation. 1998;97(10):971-978.
34. Galli SJ, et al. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005;23:749-786.
35. Thompson HL, Burbelo PD, Segui-Real B, Yamada Y, Metcalfe DD. Laminin promotes mast cell attachment. J Immunol. 1989;143(7):2323-2327.
36. Dastych J, Costa JJ, Thompson HL, Metcalfe DD. Mast cell adhesion to fibronectin. Immunology. 1991;73(4):478-484.
37. Bianchine PJ, Burd PR, Metcalfe DD. IL-3-dependent mast cells attach to plate-bound vitronectin. Demonstration of augmented proliferation in response to signals transduced via cell surface vitronectin receptors. J Immunol. 1992;149(11):3665-3671.
38. Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 2004;15(4):255-273.
39. Burstein B, Libby E, Calderone A, Nattel S. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation. 2008;117(13):1630-1641.
40. Kumagai K, et al. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol. 2003;41(12):2197-2204.
41. Nattel S, Shiroshita-Takeshita A, Brundel BJ, Rivard L. Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis. 2005;48(1):9-28.
42. Suzuki M, et al. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ Res. 2001;88(6):570-577.
43. Oka T, et al. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res. 2006;98(6):837-845.
44. Jensen BM, Swindle EJ, Iwai S, Gilfillan AM. Generation, isolation, and maintenance of rodent mast cells and mast cell lines. In Coligan, JE, Bierer, B, Margulies, DH, Shevach, EM, Strober, W, Coico, R, eds. Current Protocols in Immunology. Hoboken, NJ: John Wiley & Sons; 2006:Chapter 3:Unit 3.23.
45. Zou Y, et al. Cell type-specific angiotensin IIevoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts. Circ Res. 1998;82(3):337-345.
46. Takakura N, Yoshida H, Kunisada T, Nishikawa S, Nishikawa SI. Involvement of platelet-derived growth factor receptor-alpha in hair canal formation. J Invest Dermatol. 1996;107(5):770-777.